You have 9 free searches left this month | for more free features.

T60A

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Solid Tumors Trial (T60c injection)

Not yet recruiting
  • Malignant Solid Tumors
  • T60c injection
  • (no location specified)
Oct 7, 2023

Patisiran in Polyneuropathy of ATTRv Amyloidosis WithV122I or

Active, not recruiting
  • Hereditary Transthyretin-mediated (ATTRv) Amyloidosis
  • Polyneuropathy
  • Los Angeles, California
  • +26 more
Mar 4, 2022

Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Hangzhou, Zhejiang, China
  • +1 more
Sep 18, 2023

A Real-World Evidence Long-Term Follow-Up Study to Assess

Not yet recruiting
  • Aphakia
  • AcrySof single-piece IOL
  • AcrySof multi-piece IOL
  • (no location specified)
Mar 23, 2023

Leukemia, Acute, MDS, Myelomonocytic Leukemia, Chronic Trial (Itacitinib)

Not yet recruiting
  • Leukemia, Acute
  • +7 more
  • (no location specified)
Apr 10, 2023

B-Cell Non-Hodgkin Lymphoma, DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma Trial in Seattle (Acalabrutinib,

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 9, 2022

Influenza Trial in New Port Richey, Charlottesville (CAIV-T or TIV)

Completed
  • Influenza
  • CAIV-T or TIV
  • New Port Richey, Florida
  • +1 more
Sep 10, 2021

Idiopathic Pulmonary Fibrosis Trial in Canada (60% Oxygen, Standard of Care)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • 60% Oxygen
  • Standard of Care
  • Calgary, Alberta, Canada
  • +7 more
May 17, 2022

AML Trial in Moscow (allo-HSCT)

Recruiting
  • AML
  • allo-HSCT
  • Moscow, Russian Federation
    National Research Center for Hematology
Apr 14, 2022

Premature Infant, Respiratory Distress Syndrome Trial in Edmonton (30% group, 60% group)

Completed
  • Premature Infant
  • Respiratory Distress Syndrome
  • 30% group
  • 60% group
  • Edmonton, Alberta, Canada
    Royal Alexandra Hospital
Sep 3, 2021

Aphakia Trial in United States (Clareon Vivity/Vivity Toric Extended Vision IOL, Clareon/Clareon Toric Aspheric IOL)

Not yet recruiting
  • Aphakia
  • Clareon Vivity/Vivity Toric Extended Vision IOL
  • Clareon/Clareon Toric Aspheric IOL
  • Torrance, California
  • +6 more
May 2, 2023

B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Duarte (Best Practice, Cognitive Intervention, Comprehensive Geriatric

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Best Practice
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 19, 2023

Peripheral T Cell Lymphoma Trial in Canton (PLM60)

Withdrawn
  • Peripheral T Cell Lymphoma
  • Canton, Ohio
  • +1 more
Oct 14, 2020

Clareon IOL Retrospective Data Collection

Not yet recruiting
  • Aphakia
  • Astigmatism
  • Clareon UVA IOL
  • +2 more
  • Fort Worth, Texas
    Alcon Research, LLC
Mar 22, 2023

Allergy Trial in Worldwide (5-grass mix SLIT-drops, Placebo)

Active, not recruiting
  • Allergy
  • 5-grass mix SLIT-drops
  • Placebo
  • Brno, Czechia
  • +47 more
Aug 12, 2022

Scleroderma, Systemic Trial in Worldwide (BI 685509, Placebo)

Recruiting
  • Scleroderma, Systemic
  • BI 685509
  • Placebo
  • Liverpool, New South Wales, Australia
  • +25 more
Jan 27, 2023

NSCLC, Tumors Trial in Canada, Poland, Romania (Debio 1143, Avelumab)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Neoplasms
  • Edmonton, Alberta, Canada
  • +8 more
May 30, 2022

Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer Trial in Canada, Poland, United States

Recruiting
  • Ovarian Granulosa-Stromal Tumor
  • +2 more
  • Los Angeles, California
  • +20 more
Jul 13, 2022

NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Melanoma
  • (no location specified)
Jan 24, 2023

Essential Tremor Trial in Canada, United States (100 mg PRAX-944, 60 mg PRAX-944, Placebo)

Active, not recruiting
  • Essential Tremor
  • 100 mg PRAX-944
  • +3 more
  • Birmingham, Alabama
  • +38 more
Jan 23, 2023

Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency Trial in Worldwide (Alpha-1 MP)

Enrolling by invitation
  • Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
  • Alpha-1 MP
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

Recruiting
  • Endometrial Cancer
  • Atezolizumab - 28 Day Cycle
  • +6 more
  • Duarte, California
  • +13 more
Jun 8, 2022

Knee Osteoarthritis Trial in Roma (HYALUBRIX 60)

Recruiting
  • Knee Osteoarthritis
  • HYALUBRIX 60
  • Roma, Italy
    UOC Medicina Fisica e Riabilitativa SMC09, AOU Policlinico Umber
Oct 30, 2023

Renal Anemia Trial in Beijing (JT1801 60ug, NESP 60ug)

Recruiting
  • Renal Anemia
  • JT1801 60ug
  • NESP 60ug
  • Beijing, Beijing, China
    Peking University People's Hospital
May 17, 2023

T-cell Lymphoma Trial in Belgium, France (Lenalidomide)

Completed
  • T-cell Lymphoma
  • Bruxelles, Belgium
  • +29 more
Jul 23, 2021